Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2022

Feb 22, 2022

29821_dirs_2022-02-22_dba5203c-e933-4677-9579-9ab998638142.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2022-02-17

Reporting Person: Brown Vance R (SVP, GC and Corp. Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-02-17 Common Stock M 1000.0000 $0.0000 Acquired 31292.0000 Direct
2022-02-17 Common Stock F 332.0000 $42.8300 Disposed 30960.0000 Direct
2022-02-18 Common Stock M 741.0000 $0.0000 Acquired 31701.0000 Direct
2022-02-18 Common Stock F 214.0000 $42.5500 Disposed 31487.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-17 Restricted Stock Units $ M 1000.0000 Disposed 2025-02-17 Common Stock (1000.0000) Direct
2022-02-18 Deferred Stock Units $ M 741.0000 Disposed 2024-02-18 Common Stock (741.0000) Direct

Footnotes

F1: Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F3: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.

F4: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.